Saltiki Katerina, Voidonikola Paraskevi, Stamatelopoulos Kimon, Mantzou Emily, Papamichael Christos, Alevizaki Maria
Endocrine Unit, Evgenidion Hospital, Athens University School of Medicine, Athens, Greece.
Thyroid Res. 2008 Sep 29;1(1):3. doi: 10.1186/1756-6614-1-3.
Overt hypothyroidism has been associated with arterial hypertension and increased arterial stiffness. Results in euthyroid individuals have been conflicting. We investigated associations of thyroid function with systolic (SAP) and diastolic (DAP) arterial pressure in euthyroid subjects.
311 euthyroid individuals (185 women, mean age 43.9 +/- 9) without a history of diabetes attending a preventive medicine program were examined. Subjects receiving thyroxine (10.6%) were excluded; 19.3% had hypertension, 43% had a family history for hypertension. TSH, fT4, thyroid autoantibodies, insulin, glucose were measured. The "fT4.TSH product", which has been suggested as a T4 resistance-index, was calculated.
TSH range was 0.1-8, median 1.4 mU/L, fT4 range was 11.5-25.2 pmol/L, median 17.4. TSH and the "fT4.TSH product" were positively associated with DAP (p < 0.03, for both associations). In the subgroup of individuals with TSH levels 0.36-2.5 mU/L, both TSH and the "fT4.TSH product" were positively correlated with SAP (r = +0.133 p = 0.044, r = +0.152 p = 0.026) and DAP (r = +0.243 p < 0.001, r = +0.252 p < 0.001 respectively); in multivariate analysis the "fT4.TSH product" was a significant predictor of DAP independently of HOMA-IR and BMI (p < 0.001). Similar associations were found when only the non-hypertensive subjects were analysed (p = 0.004). Hypertensive patients had higher TSH levels (p = 0.02) and belonged more frequently to the subgroup with TSH > 2 mU/L (35.3% vs 21.3%, p = 0.045).
In euthyroid individuals the association of thyroid function with diastolic arterial pressure remains significant even when a stricter "normal range" for TSH levels is considered. The "freeT4.TSH" product appears to be an even stronger predictor of DAP, independently of HOMA insulin resistance index and obesity.
显性甲状腺功能减退与动脉高血压及动脉僵硬度增加有关。甲状腺功能正常个体的相关研究结果存在矛盾。我们调查了甲状腺功能正常受试者的甲状腺功能与收缩压(SAP)和舒张压(DAP)之间的关联。
对311名参加预防医学项目、无糖尿病史的甲状腺功能正常个体(185名女性,平均年龄43.9±9岁)进行检查。排除接受甲状腺素治疗的受试者(10.6%);19.3%患有高血压,43%有高血压家族史。检测促甲状腺激素(TSH)、游离甲状腺素(fT4)、甲状腺自身抗体、胰岛素、血糖。计算被认为是T4抵抗指数的“fT4.TSH乘积”。
TSH范围为0.1 - 8,中位数为1.4 mU/L,fT4范围为11.5 - 25.2 pmol/L,中位数为17.4。TSH和“fT4.TSH乘积”与DAP呈正相关(两种关联的p均<0.03)。在TSH水平为0.36 - 2.5 mU/L的个体亚组中,TSH和“fT4.TSH乘积”与SAP(r = +0.133,p = 0.044;r = +0.152,p = 0.026)及DAP(分别为r = +0.243,p < 0.001;r = +0.252,p < 0.001)均呈正相关;在多变量分析中,“fT4.TSH乘积”是DAP的显著预测因子,独立于稳态模型评估胰岛素抵抗(HOMA-IR)和体重指数(BMI)(p < 0.001)。仅分析非高血压受试者时也发现了类似的关联(p = 0.004)。高血压患者的TSH水平更高(p = 0.02),且更频繁地属于TSH>2 mU/L的亚组(35.3%对21.3%,p = 0.045)。
在甲状腺功能正常个体中,即使考虑更严格的TSH水平“正常范围”,甲状腺功能与舒张压之间的关联仍然显著。“游离T4.TSH”乘积似乎是DAP更强的预测因子,独立于HOMA胰岛素抵抗指数和肥胖。